Executive record

Nicole Lemerond

Director at MEDICINOVA INC

Follow
More
Challenge a Claim

Alpha ID: alpha:person:nicole-lemerondVersion: public-0As of: 2026-09-30

Not yet claimed9 published Claims6 sources
  • Director

Key Claims

Biography

Nicole Lemerond is a financial executive with over 25 years of experience in investment management, private equity, investment banking, and mergers/acquisitions. She served as Managing Partner of NV Capital and has extensive experience investing in healthcare companies and executing complex transactions.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

6 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. INM DEF 14A director slate

    sec filing · Source published: Nov 3, 2025 · Retrieved: May 16, 2026

    Supports 2 claims
    • Board role: Board role: Director · Claim reviewed: May 16, 2026
    • Committee assignments: Committee assignments: Audit, Compensation, Nominating/Governance · Claim reviewed: May 16, 2026
  2. Open source

    sec proxy · Source published: Nov 3, 2025 · Retrieved: Apr 28, 2026

    Supports 1 claim
    • Professional Role: Director at InMed Pharmaceuticals Inc. · Claim reviewed: May 16, 2026
  3. MNOV DEF 14A director slate

    sec filing · Source published: Apr 28, 2025 · Retrieved: May 16, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Board role: Board role: Director · Claim reviewed: May 16, 2026
    • Committee assignments: Committee assignments: Audit, Compensation, Nominating/Governance · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026
  4. Open source

    sec proxy · Source published: Apr 28, 2025 · Retrieved: Apr 28, 2026

    Supports 1 claim
    • Professional Role: Director at MEDICINOVA INC · Claim reviewed: May 16, 2026
  5. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of MEDICINOVA INC · Claim reviewed: May 16, 2026
  6. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of InMed Pharmaceuticals Inc. · Claim reviewed: May 16, 2026